The September 2023 quarter revenue stood at Rs. 1635.96 millions, up 11.30% as compared to Rs. 1469.88 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2023 is Rs. -209.56 millions as compared to Net Profit of Rs. 190.37 millions of corresponding quarter ended September 2022The company reported a degrowth in operating Profit to 198.82 millions from 289.79 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1635.96 1469.88 11.30 3059.47 2779.94 10.06 6167.34 5201.35 18.57
Other Income 12.59 8.54 47.42 23.61 14.73 60.29 43.20 27.62 56.41
PBIDT 198.82 289.79 -31.39 463.45 525.21 -11.76 1269.82 1079.38 17.64
Interest 7.73 4.49 72.16 12.82 6.31 103.17 24.14 64.07 -62.32
PBDT -126.45 285.30 -144.32 133.09 518.90 -74.35 1245.68 1015.31 22.69
Depreciation 34.03 28.19 20.72 68.28 58.57 16.58 123.42 100.80 22.44
PBT -160.48 257.11 -162.42 64.81 460.33 -85.92 1122.26 914.51 22.72
TAX 49.08 66.74 -26.46 105.77 121.33 -12.82 288.82 195.04 48.08
Deferred Tax 6.54 6.21 5.31 9.85 10.84 -9.13 25.05 27.83 -9.99
PAT -209.56 190.37 -210.08 -40.96 339.00 -112.08 833.44 719.47 15.84
Equity 368.81 364.37 1.22 368.81 364.37 1.22 364.37 364.37 0.00
PBIDTM(%) 12.15 19.72 -38.36 15.15 18.89 -19.82 20.59 20.75 -0.78

Acutaas Chemicals Share Price

2053.25 37.00 (1.84%)
16-Feb-2026 09:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1707.80
Dr. Reddys Lab 1268.35
Cipla 1339.05
Zydus Lifesciences 911.10
Lupin 2222.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×